Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose febuxostat versus low-dose benzbromarone in primary gout
ChiCTR1800019352Phase 4Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in gout and hyperuricemia comparing Febuxostat group with Benzbromarone group (2 arms). Primary endpoints: Target rate of serum uric acid and Decrease in serum uric acid. Started Jan 2016; status: completed.
02
Drugs
febuxostatbenzbromarone
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on ChiCTR1800019352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019352.